Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Double-digit rise in TB (tuberculosis) ignites detection concerns - new strategy ahead

This article was originally published in Clinica

Executive Summary

The UK's Health Protection Agency (HPA) has reported a 10.8% rise in tuberculosis cases in 2005, the largest annual increase since surveillance was introduced in 1999. While underlining the need for tight monitoring of the situation, backed by early diagnostic testing, new data concerning TB incubation among non-UK-born citizens and the likely entry of the disease from abroad add weight to the concept of targeting screening activities at these population groups.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel